Autor: |
Grimm WD; Periodontology, University of Witten, Germany., Dannan A; Periodontology, Syrian Private University - Damascus, Syrian Arab Republic., Giesenhagen B; Implantology, Implantogy Center Kassel, Germany., Schau I; Implantology, Implantology Center Detmold, Germany., Varga G; Cell Biology, SE University Budapest, Hungary., Vukovic MA; Implantology, Praxisteam Hasslinghausen, Germany., Sirak SV; Stomatology, Stavropol State Medical University, Stavropol, Russia. |
Jazyk: |
angličtina |
Zdroj: |
International journal of stem cells [Int J Stem Cells] 2014 May; Vol. 7 (1), pp. 23-9. |
DOI: |
10.15283/ijsc.2014.7.1.23 |
Abstrakt: |
The management of facial defects has rapidly changed in the last decade. Functional and esthetic requirements have steadily increased along with the refinements of surgery. In the case of advanced atrophy or jaw defects, extensive horizontal and vertical bone augmentation is often unavoidable to enable patients to be fitted with implants. Loss of vertical alveolar bone height is the most common cause for a non primary stability of dental implants in adults. At present, there is no ideal therapeutic approach to cure loss of vertical alveolar bone height and achieve optimal pre-implantological bone regeneration before dental implant placement. Recently, it has been found that specific populations of stem cells and/or progenitor cells could be isolated from different dental resources, namely the dental follicle, the dental pulp and the periodontal ligament. Our research group has cultured palatal-derived stem cells (paldSCs) as dentospheres and further differentiated into various cells of the neuronal and osteogenic lineage, thereby demonstrating their stem cell state. In this publication will be shown whether paldSCs could be differentiated into the osteogenic lineage and, if so, whether these cells are able to regenerate alveolar bone tissue in vivo in an athymic rat model. Furthermore, using these data we have started a proof of principle clinical- and histological controlled study using stem cell-rich palatal tissues for improving the vertical alveolar bone augmentation in critical size defects. The initial results of the study demonstrate the feasibility of using stem cell-mediated tissue engineering to treat alveolar bone defects in humans. |
Databáze: |
MEDLINE |
Externí odkaz: |
|